In this update we added a new monograph for DURVALUMAB.

We also added new stability information to the monographs for CARMUSTINE, CETUXIMAB, CISATRACURIUM BESYLATE, MITOMYCIN, PEMETREXED, and THIOTEPA.

New compatibility information was added to the existing drug monographs for ALPROSTADIL, AMPICILLIN SODIUM, AMPICILLIN SODIUM – SULBACTAM SODIUM, BUMETANIDE, CEFOTAXIME SODIUM, CEFTRIAXONE, DEXMEDETOMIDINE HYDROCHLORIDE, DIHYDROERGOTAMINE MESYLATE, DOPAMINE HYDROCHLORIDE, FUROSEMIDE, HEPARIN SODIUM, HYDROMORPHONE HYDROCHLORIDE, KETAMINE HYDROCHLORIDE, LACOSAMIDE, MORPHINE HYDROCHLORIDE, NICARDIPINE HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, POTASSIUM CHLORIDE, ROCURONIUM BROMIDE, SILDENAFIL CITRATE, TOTAL PARENTERAL NUTRITION SOLUTIONS, VANCOMYCIN HYDROCHLORIDE, and VASOPRESSIN.